Bioatla, INC 8-K filings

BioAtla, Inc. has awarded cash bonuses and restricted stock units to its executive officers based on the achievement of 2023 clinical, research, and business objectives, and has also approved a 2024 corporate bonus plan.

BioAtla is facing a class action lawsuit challenging certain advance notice bylaw provisions, leading the board to temporarily waive enforcement of those provisions for the upcoming annual meeting.